REPLReplimune Group, Inc.
$13.03+178% 1Y
$13.03
$1.7052 weeks$15.97
REPL as reported
- Net income
- −$297M
Net income · +6.0% year on year · trailing twelve months to Q1 2027
- Free cash flow
- −$281M
Free cash flow · +23% year on year · trailing twelve months to Q1 2027
- EPS
- −$3.15
EPS · −2.8% year on year · trailing twelve months to Q1 2027
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$297M | +6.0% | Q1 2027 |
| EPS | −$3.15 | −2.8% | Q1 2027 |
| ROE | −184% | n/a | Q1 2027 |
| ROA | −97% | n/a | Q1 2027 |
| ROIC | 2450% | n/a | Q1 2027 |
| Free cash flow | −$281M | +23% | Q1 2027 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Replimune Group, Inc. (REPL) · Net incomeNet incomeReplimune Group, Inc. (REPL)